Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thromboembolic Complications Post-COVID-19: What is the Risk in Mild-Moderate Cases?

NCT06695377 is registered in ClinicalTrials.gov with Marmara University Pendik Training and Research Hospital as lead sponsor.

NCT NCT06695377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06695377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thromboembolic Complications Post-COVID-19: What is the Risk in Mild-Moderate Cases?
Lead sponsor
Marmara University Pendik Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
September 30, 2022
Enrollment
961 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19, post covid-19, thromboembolic and bleeding complications, thromboembolism, venous